Home/Products /voglibose-i-point-p-point-0-point-2-tablets

Voglibose 0.2mg Tablet in PCD pharma franchise in Hyderabad

Voglibose 0.2mg Tablet in pharmaceutical manufacturing company in Mumbai

Voglibose 0.2mg Tablet in pharma franchise in Pune

Voglibose 0.2mg Tablet in pharma suppliers in Delhi

Voglibose 0.2mg Tablet in pharma export companies in Kolkata

Voglibose 0.2mg Tablet in pharma franchise opportunities in Bengaluru

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Stimulant

Urology

Voglibose 0.2mg Tablet | Antidiabetic Care | Best Price for PCD Pharma Franchise

Voglibose Tablet | Diabetes Segment | Best Price from Third-Party Manufacturers in India

Voglibose 0.2mg | Postprandial Sugar Control | Best Price from Pharma Export Companies in India

Voglibose Tablet | Oral Antidiabetic | Best Price from Top Pharma Company

Vogliviga 0.2 Tablet | Antidiabetic Care | Best Price in the Antidiabetic Pharma Franchise

Vogliviga 0.2 Tablet

Composition : Voglibose I.P. 0.2 Tablets

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹89/-

Please Contact For Best Price

Vogliviga 0.2 Tablet contains Voglibose 0.2mg, an oral alpha-glucosidase inhibitor used in the management of type 2 diabetes mellitus. It works by delaying the digestion and absorption of carbohydrates in the intestine, thereby preventing a sudden spike in postprandial (after meal) blood sugar levels. Vogliviga 0.2 Tablet is especially useful in patients whose blood glucose levels are not adequately controlled by diet, exercise, or other oral antidiabetics. It complements other antidiabetic therapies by targeting post-meal glucose control without causing hypoglycemia when used alone.

About the Product

May cause flatulence, abdominal discomfort, bloating, or diarrhea. These side effects are generally mild and subside with continued use. Rarely, serious gastrointestinal disturbances may occur.

Used for the management of postprandial hyperglycemia in patients with type 2 diabetes mellitus, as part of an overall diabetes treatment plan including diet and exercise.

Not recommended for patients with inflammatory bowel disease, intestinal obstruction, or chronic digestive disorders. Regular monitoring of blood glucose is essential. Should be used under medical supervision, particularly in patients with renal or hepatic impairment.

Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of the reach of children.